A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

BACKGROUND: Glycopyrronium tosylate is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years (Qbrexza™ [glycopyrronium] cloth, 2.4%). OBJECTIVE: This 44-week open-label extension study assessed glycopyrronium tosylate safety and descriptive effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaser, Dee Anna, Hebert, Adelaide A., Nast, Alexander, Werschler, William P., Green, Lawrence, Mamelok, Richard D., Quiring, John, Drew, Janice, Pariser, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687675/
https://www.ncbi.nlm.nih.gov/pubmed/31111409
http://dx.doi.org/10.1007/s40257-019-00446-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687675/
https://www.ncbi.nlm.nih.gov/pubmed/31111409
http://dx.doi.org/10.1007/s40257-019-00446-6

Ejemplares similares